Gene · 6329
Papers1,928
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,928
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biophysical and structural insights into the SCN4A E452K variant linked to myotonia and paramyotonia congenita. | Sci Rep | 2025 | 41006520 | PubTator, text mining | PubMed |
| Modification of Closed-State Inactivation in Voltage-Gated Sodium Channel Nav1.7 by Two Novel Arachnid Toxins. | Toxins (Basel) | 2025 | 41003497 | PubTator, text mining | PubMed |
| Genetic analysis of a family with skeletal muscle ion channelopathy and hereditary spastic paraplegia type 7 caused by SCN4A and SPG7 double mutations. | Gene | 2025 | 40998070 | PubTator, text mining | PubMed |
| Epidemiological report and diagnostic approach used in the neuromuscular population of Liege, Belgium. | Orphanet J Rare Dis | 2025 | 40883749 | PubTator, text mining | PubMed |
| Clinical, electromyographic, and biophysical characterization of the rare Nav1.4 channel mutation SCN4A L1436P. | Front Physiol | 2025 | 40843127 | PubTator, text mining | PubMed |
| COVID-19 infection and intense physical activity in hypokalemic periodic paralysis. | Bol Med Hosp Infant Mex | 2025 | 40829572 | PubTator, text mining | PubMed |
| Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery. | FASEB J | 2025 | 40814286 | PubTator, text mining | PubMed |
| Multidimensional pan cancer analysis of the sodium induced cell death gene TRPM4. | Sci Rep | 2025 | 40804073 | PubTator, text mining | PubMed |
| Molecular genetics of skeletal muscle channelopathies. | J Hum Genet | 2025 | 40770230 | PubTator, text mining | PubMed |
| Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy. | Eur J Neurol | 2025 | 40755160 | PubTator, text mining | PubMed |
| Neck muscle hypertrophy in paramyotonia congenita caused by a missense variant in the SCN4A gene (p.Val445Met). | Acta Neurol Belg | 2025 | 40707763 | PubTator, text mining | PubMed |
| Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, and Applications. | Chem Rev | 2025 | 40698392 | PubTator, text mining | PubMed |
| From traditional medicine to targeted therapy: Structure-activity relationship-guided optimization of scorpion toxin DKK2 for pain-associated sodium channel blockade. | J Ethnopharmacol | 2025 | 40615098 | PubTator, text mining | PubMed |
| Using network toxicology and molecular docking to identify core targets and pathways underlying tacrolimus-induced tremor in organ transplant recipients. | Sci Rep | 2025 | 40592862 | PubTator, text mining | PubMed |
| Expansion microscopy reveals nano-scale insights into the human neuromuscular junction. | Cell Rep Methods | 2025 | 40527289 | PubTator, text mining | PubMed |
| High-dose flecainide for symptomatic relief in paramyotonia congenita/severe neonatal episodic laryngospasm due to SCN4A G1306E: a case report. | J Med Case Rep | 2025 | 40361141 | PubTator, text mining | PubMed |
| Novel SCN4A Variants Associated With Myalgic Myotonic Disorder or Paramyotonia. | Eur J Neurol | 2025 | 40344301 | PubTator, text mining | PubMed |
| SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure. | Eur J Pharmacol | 2025 | 40222442 | PubTator, text mining | PubMed |
| Semaglutide reverses the chronic myopathy of hyperkalemic periodic paralysis: a case report. | BMC Nephrol | 2025 | 40197299 | PubTator, text mining | PubMed |
| Pharmacological therapy of non-dystrophic myotonias. | Acta Myol | 2025 | 40183437 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6329/papers?page=3